GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Enzo Biochem Inc (NYSE:ENZ) » Definitions » E10

Enzo Biochem (Enzo Biochem) E10 : $0.01 (As of Jan. 2024)


View and export this data going back to 1980. Start your Free Trial

What is Enzo Biochem E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Enzo Biochem's adjusted earnings per share data for the three months ended in Jan. 2024 was $-0.060. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $0.01 for the trailing ten years ended in Jan. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Enzo Biochem was 41.50% per year. The lowest was -135.10% per year. And the median was 6.95% per year.

As of today (2024-04-29), Enzo Biochem's current stock price is $1.05. Enzo Biochem's E10 for the quarter that ended in Jan. 2024 was $0.01. Enzo Biochem's Shiller PE Ratio of today is 105.00.

During the past 13 years, the highest Shiller PE Ratio of Enzo Biochem was 162.00. The lowest was 105.00. And the median was 136.50.


Enzo Biochem E10 Historical Data

The historical data trend for Enzo Biochem's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzo Biochem E10 Chart

Enzo Biochem Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.22 -0.22 -0.17 -0.09 0.01

Enzo Biochem Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.11 -0.12 0.01 - 0.01

Competitive Comparison of Enzo Biochem's E10

For the Diagnostics & Research subindustry, Enzo Biochem's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Enzo Biochem's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Enzo Biochem's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Enzo Biochem's Shiller PE Ratio falls into.



Enzo Biochem E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Enzo Biochem's adjusted earnings per share data for the three months ended in Jan. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jan. 2024 (Change)*Current CPI (Jan. 2024)
=-0.06/129.4194*129.4194
=-0.060

Current CPI (Jan. 2024) = 129.4194.

Enzo Biochem Quarterly Data

per share eps CPI Adj_EPS
201404 -0.010 100.023 -0.013
201407 -0.070 100.520 -0.090
201410 -0.080 100.176 -0.103
201501 -0.090 98.604 -0.118
201504 -0.060 99.824 -0.078
201507 0.190 100.691 0.244
201510 0.100 100.346 0.129
201601 0.150 99.957 0.194
201604 -0.050 100.947 -0.064
201607 0.770 101.524 0.982
201610 -0.030 101.988 -0.038
201701 -0.020 102.456 -0.025
201704 -0.002 103.167 -0.003
201707 0.002 103.278 0.003
201710 -0.010 104.070 -0.012
201801 -0.020 104.578 -0.025
201804 -0.060 105.708 -0.073
201807 -0.120 106.324 -0.146
201810 -0.130 106.695 -0.158
201901 -0.180 106.200 -0.219
201904 0.470 107.818 0.564
201907 -0.110 108.250 -0.132
201910 -0.160 108.577 -0.191
202001 -0.160 108.841 -0.190
202004 -0.210 108.173 -0.251
202007 -0.070 109.318 -0.083
202010 0.010 109.861 0.012
202101 0.050 110.364 0.059
202104 0.040 112.673 0.046
202107 0.060 115.183 0.067
202110 -0.050 116.696 -0.055
202201 -0.050 118.619 -0.055
202204 -0.100 121.978 -0.106
202207 -0.180 125.002 -0.186
202210 -0.220 125.734 -0.226
202301 -0.230 126.223 -0.236
202304 -0.310 127.992 -0.313
202307 1.170 128.974 1.174
202310 -0.130 129.810 -0.130
202401 -0.060 129.419 -0.060

Add all the adjusted EPS together and divide 10 will get our e10.


Enzo Biochem  (NYSE:ENZ) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Enzo Biochem's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=1.05/0.01
=105.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Enzo Biochem was 162.00. The lowest was 105.00. And the median was 136.50.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Enzo Biochem E10 Related Terms

Thank you for viewing the detailed overview of Enzo Biochem's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Enzo Biochem (Enzo Biochem) Business Description

Traded in Other Exchanges
Address
527 Madison Avenue, New York, NY, USA, 10022
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. It focuses on delivering and applying its technology to produce products and services to allow its customers to meet their clinical needs. The company has Enzo clinical labs, Enzo life sciences, Enzo therapeutics operating segments. It derives the majority of its revenues from the Clinical lab's segment.
Executives
Steven J Pully director 9800 RICHMOND AVE, SUITE 700, HOUSTON TX 77042
James G. Wolf 10 percent owner 105, FLYWAY DRIVE, KIAWAH ISLAND SC 29455
Hamid Erfanian officer: Chief Executive Officer 527 MADISON AVENUE, NEW YORK NY 10022
Patricia Eckert officer: Interim CFO C/O ENZO BIOCHEM, INC., 81 EXECUTIVE BLVD, SUITE 3, FARMINGDALE NY 11735
Kara Cannon officer: Chief Operating Officer 527 MADISON AVE, NEW YORK NY 10022
Bradley Louis Radoff director 2727 KIRBY DRIVE, UNIT 29L, HOUSTON TX 77098
David Bench officer: CHIEF FINANCIAL OFFICER ENZO BIOCHEM, INC., 527 MADISON AVENUE, NEW YORK NY 10022
Harbert Discovery Fund, Lp 10 percent owner HARBERT DISCOVERY FUND GP, LLC, 2100 THIRD AVENUE NORTH, SUITE 600, BIRMINGHAM AL 35203
Ian B. Walters director ENZO BIOCHEM, INC., 527 MADISON AVENUE, NEW YORK NY 10022
Mary Tagliaferri director 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO CA 94158
Clemens Peter J Iv 10 percent owner 2383 N. BERRY'S CHAPEL RD., FRANKLIN TN 37069
Rebecca J. Fischer director ENZO BIOCHEM, INC., 527 MADISON AVENUE, NEW YORK NY 10022
Fabian Blank 10 percent owner, other: See Remarks ROEMERSTRASSE 6, BAD BERTRICH 2M 56864
Harbert Management Corp 10 percent owner 2100 THIRD AVENUE NORTH, SUITE 600, BIRMINGHAM AL 35203
Harbert Discovery Co-investment Fund I Gp, Llc 10 percent owner 2100 THIRD AVENUE NORTH, SUITE 600, BIRMINGHAM AL 35203